20-35954044-C-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_033630.3(SCAND1):āc.241G>Cā(p.Val81Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000389 in 1,541,564 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_033630.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCAND1 | NM_033630.3 | c.241G>C | p.Val81Leu | missense_variant | 2/2 | ENST00000305978.7 | NP_361012.3 | |
SCAND1 | NM_001385710.1 | c.241G>C | p.Val81Leu | missense_variant | 3/3 | NP_001372639.1 | ||
SCAND1 | NM_016558.4 | c.241G>C | p.Val81Leu | missense_variant | 3/3 | NP_057642.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCAND1 | ENST00000305978.7 | c.241G>C | p.Val81Leu | missense_variant | 2/2 | 1 | NM_033630.3 | ENSP00000301995.2 | ||
SCAND1 | ENST00000373991.3 | c.241G>C | p.Val81Leu | missense_variant | 3/3 | 1 | ENSP00000363103.3 | |||
SCAND1 | ENST00000615116.1 | c.241G>C | p.Val81Leu | missense_variant | 3/3 | 5 | ENSP00000481289.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152202Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000144 AC: 2AN: 1389362Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 684162
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74362
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at